HFS
VRTX icon

Hantz Financial Services’s Vertex Pharmaceuticals VRTX Stock Holding History

Hantz Financial Services’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.28M Sell
16,664
-1,143
-6% -$507K 0.11% 114
2026
Q1 		$7.95M Buy
17,807
+10,616
+148% +$4.95M 0.12% 115
2025
Q4 		$3.26M Buy
7,191
+961
+15% +$414K 0.05% 250
2025
Q3 		$2.44M Buy
6,230
+4,864
+356% +$2.03M 0.04% 303
2025
Q2 		$608K Sell
1,366
-18
-1% -$8.29K 0.01% 497
2025
Q1 		$671K Buy
1,384
+126
+10% +$58.7K 0.01% 473
2024
Q4 		$507K Sell
1,258
-2,286
-65% -$1.06M 0.01% 500
2024
Q3 		$1.65M Buy
3,544
+69
+2% +$33.1K 0.03% 365
2024
Q2 		$1.63M Buy
3,475
+3,437
+9,045% +$1.49M 0.03% 354
2024
Q1 		$16K Hold
38
– – ﹤0.01% 783
2023
Q4 		$15K Hold
38
– – ﹤0.01% 766
2023
Q3 		$13K Hold
38
– – ﹤0.01% 777
2023
Q2 		$13K Buy
+38
New +$12.8K ﹤0.01% 757
2022
Q1 		– Sell
-91
Closed -$20K – 1124
2021
Q4 		$20K Sell
91
-9
-9% -$1.75K ﹤0.01% 624
2021
Q3 		$18K Sell
100
-2,395
-96% -$468K ﹤0.01% 631
2021
Q2 		$503K Buy
2,495
+656
+36% +$137K 0.02% 391
2021
Q1 		$395K Buy
1,839
+692
+60% +$152K 0.02% 392
2020
Q4 		$271K Buy
1,147
+755
+193% +$173K 0.01% 381
2020
Q3 		$107K Buy
+392
New +$108K 0.01% 426

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Hantz Financial Services's VRTX Position: Q2 2026 in Review

Hantz Financial Services reduced its Vertex Pharmaceuticals (VRTX) stake by 6.4% in Q2 2026, selling an estimated $507K and leaving 16,664 shares worth $8.28M. The position accounts for 0.11% of the portfolio, ranked #114.

Hantz Financial Services first reported a position in VRTX in Q3 2020 and has held it in 19 quarters since. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Hantz Financial Services held 16,664 shares of Vertex Pharmaceuticals worth $8.28M as of Q2 2026.
  • Hantz Financial Services sold 1,143 Vertex Pharmaceuticals shares in Q2 2026, an estimated $507K.
  • Vertex Pharmaceuticals made up 0.11% of Hantz Financial Services's portfolio in Q2 2026, its #114 holding.
  • Hantz Financial Services first reported a position in Vertex Pharmaceuticals in Q3 2020 and has held it in 19 quarters since.
  • 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.